These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 39252705)
1. Efficacy and Safety of Terlipressin Infusion in Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): A Retrospective Observational Study. Gowda M; Dilipbhai DM; Jalihal U; Kumar MP; Gowda S B; Jain A; Ganjoo N Cureus; 2024 Aug; 16(8):e66581. PubMed ID: 39252705 [TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review. Flamm SL; Wong F; Ahn J; Kamath PS Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500 [TBL] [Abstract][Full Text] [Related]
3. INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion. Weinberg E; Rahematpura S; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Ikahihifo-Bender J; Harte M; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K; Fricker Z; Reddy KR Contemp Clin Trials Commun; 2023 Dec; 36():101211. PubMed ID: 37953795 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population. Reddy KR; Weinberg EM; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Fricker Z; Ikahihifo-Bender J; Harte M; Garcia S; Campbell K; Olofson A; Razavi RF; James JM; Patel H; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K Liver Transpl; 2024 Oct; 30(10):1026-1038. PubMed ID: 38771635 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study. Kulkarni AV; Ravikumar ST; Tevethia H; Premkumar M; Kumar K; Sharma M; Gupta R; Rao PN; Reddy DN Sci Rep; 2022 Apr; 12(1):5503. PubMed ID: 35365736 [TBL] [Abstract][Full Text] [Related]
6. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review. Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969 [TBL] [Abstract][Full Text] [Related]
7. Delhi Model: A New Tool for Predicting Response to Terlipressin in Hepatorenal Syndrome-Acute Kidney Injury. Agrawal J; Kumar A; Sharma P; Bansal N; Singla V; Sharma S; Arora A J Clin Exp Hepatol; 2024; 14(1):101266. PubMed ID: 38107184 [TBL] [Abstract][Full Text] [Related]
8. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis. Ma AT; Solé C; Juanola A; Escudé L; Napoleone L; Avitabile E; Pérez-Guasch M; Carol M; Pompili E; Gratacós-Ginés J; Soria A; Rubio AB; Cervera M; Moreta MJ; Morales-Ruiz M; Solà E; Poch E; Fabrellas N; Graupera I; Pose E; Ginès P J Hepatol; 2024 Sep; 81(3):441-450. PubMed ID: 38479614 [TBL] [Abstract][Full Text] [Related]
9. Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure-acute kidney injury - an open label RCT. Gupta T; Goel A; Ranga N; Goyal SK Clin Exp Hepatol; 2023 Dec; 9(4):351-358. PubMed ID: 38774204 [TBL] [Abstract][Full Text] [Related]
10. Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies. Singal AK; Palmer G; Melick L; Abdallah M; Kwo P Gastro Hep Adv; 2023; 2(4):455-464. PubMed ID: 39132033 [TBL] [Abstract][Full Text] [Related]
11. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC; Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734 [TBL] [Abstract][Full Text] [Related]